JP2022163194A5 - - Google Patents

Download PDF

Info

Publication number
JP2022163194A5
JP2022163194A5 JP2022129624A JP2022129624A JP2022163194A5 JP 2022163194 A5 JP2022163194 A5 JP 2022163194A5 JP 2022129624 A JP2022129624 A JP 2022129624A JP 2022129624 A JP2022129624 A JP 2022129624A JP 2022163194 A5 JP2022163194 A5 JP 2022163194A5
Authority
JP
Japan
Prior art keywords
conjugate
daltons
seq
ethylene glycol
poly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022129624A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022163194A (ja
Filing date
Publication date
Priority claimed from PCT/US2016/022146 external-priority patent/WO2016145388A1/en
Application filed filed Critical
Publication of JP2022163194A publication Critical patent/JP2022163194A/ja
Publication of JP2022163194A5 publication Critical patent/JP2022163194A5/ja
Pending legal-status Critical Current

Links

JP2022129624A 2015-03-11 2022-08-16 Il-7部分とポリマーとのコンジュゲート Pending JP2022163194A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562131634P 2015-03-11 2015-03-11
US62/131,634 2015-03-11
PCT/US2016/022146 WO2016145388A1 (en) 2015-03-11 2016-03-11 Conjugates of an il-7 moiety and an polymer
JP2017547157A JP2018510863A (ja) 2015-03-11 2016-03-11 Il−7部分とポリマーとのコンジュゲート

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017547157A Division JP2018510863A (ja) 2015-03-11 2016-03-11 Il−7部分とポリマーとのコンジュゲート

Publications (2)

Publication Number Publication Date
JP2022163194A JP2022163194A (ja) 2022-10-25
JP2022163194A5 true JP2022163194A5 (https=) 2023-01-04

Family

ID=56878892

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017547157A Withdrawn JP2018510863A (ja) 2015-03-11 2016-03-11 Il−7部分とポリマーとのコンジュゲート
JP2021031726A Pending JP2021091708A (ja) 2015-03-11 2021-03-01 Il−7部分とポリマーとのコンジュゲート
JP2022129624A Pending JP2022163194A (ja) 2015-03-11 2022-08-16 Il-7部分とポリマーとのコンジュゲート

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2017547157A Withdrawn JP2018510863A (ja) 2015-03-11 2016-03-11 Il−7部分とポリマーとのコンジュゲート
JP2021031726A Pending JP2021091708A (ja) 2015-03-11 2021-03-01 Il−7部分とポリマーとのコンジュゲート

Country Status (11)

Country Link
US (1) US20190290733A1 (https=)
EP (1) EP3285799A4 (https=)
JP (3) JP2018510863A (https=)
KR (2) KR20250052471A (https=)
CN (1) CN107405384A (https=)
AU (1) AU2016228555B2 (https=)
CA (1) CA2978330C (https=)
IL (1) IL254389B2 (https=)
MA (1) MA41957A (https=)
MX (1) MX391071B (https=)
WO (1) WO2016145388A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2295450B1 (en) 2000-09-29 2015-01-28 Merck Sharp & Dohme Corp. Pegylated interleukin-10
EP2066336B1 (en) 2006-09-28 2012-09-19 Merck Sharp & Dohme Corp. Use of pegylated il-10 to treat cancer
MX2015014438A (es) 2013-04-18 2016-05-18 Armo Biosciences Inc Metodos de uso de interleucina-10 para tratar enfermedades y trastornos.
EP3010527B1 (en) 2013-06-17 2018-08-08 Armo Biosciences, Inc. Method for assessing protein identity and stability
CN120242030A (zh) 2013-11-11 2025-07-04 阿尔莫生物科技股份有限公司 将白细胞介素-10用于治疗疾病和病症的方法
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US20160361415A1 (en) 2015-05-28 2016-12-15 Armo Biosciences, Inc. Methods of Using Interleukin-10 for Treating Diseases and Disorders
KR20180038553A (ko) 2015-08-25 2018-04-16 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
EP3894387A4 (en) 2018-12-12 2023-07-19 Levim Biotech LLP ACYLATION PROCESSES FOR THE PRODUCTION OF N-SUBSTITUTED PEPTIDES
WO2022020637A1 (en) * 2020-07-22 2022-01-27 Nektar Therapeutics Il-7 receptor agonist composition and related methods and uses
EP4463135A2 (en) 2022-01-10 2024-11-20 Sana Biotechnology, Inc. Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses
WO2023193015A1 (en) 2022-04-01 2023-10-05 Sana Biotechnology, Inc. Cytokine receptor agonist and viral vector combination therapies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666400B2 (en) * 2005-04-06 2010-02-23 Ibc Pharmaceuticals, Inc. PEGylation by the dock and lock (DNL) technique
WO2002085300A2 (en) * 2001-04-23 2002-10-31 The Regents Of The University Of California Methods of using interleukin-7 to modulate physiological processes in mammalian pulmonary fibroblasts
WO2003044056A2 (en) * 2001-11-20 2003-05-30 Pharmacia Corporation Chemically-modified human growth hormone conjugates
EP1391513A1 (en) * 2002-08-08 2004-02-25 Cytheris IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof
GEP20084487B (en) * 2002-12-26 2008-09-25 Mountain View Pharmaceuticals Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof
RU2437893C2 (ru) * 2004-12-09 2011-12-27 Мерк Патент Гмбх Варианты il-7 со сниженной иммуногенностью
CA2711503A1 (en) * 2008-01-08 2009-07-16 Biogenerix Ag Glycoconjugation of polypeptides using oligosaccharyltransferases
WO2012065086A1 (en) * 2010-11-12 2012-05-18 Nektar Therapeutics Conjugates of an il-2 moiety and a polymer
CN102145178B (zh) * 2011-04-15 2012-09-26 北京凯因科技股份有限公司 Peg化白介素15
WO2013020079A2 (en) * 2011-08-04 2013-02-07 Nektar Therapeutics Conjugates of an il-11 moiety and a polymer
CA2855675C (en) * 2011-11-14 2020-11-03 Emory University Conjugates of gm-csf and il-7, compositions and methods related thereto

Similar Documents

Publication Publication Date Title
JP2022163194A5 (https=)
CN1134265C (zh) 用作为免疫佐剂的磷腈聚电解质
CN115197078B (zh) 一种聚乙二醇化脂质及其修饰的脂质体、含该脂质体的药物组合物及其制剂和应用
JP2004520473A5 (https=)
TW585772B (en) Pharmaceutical composition for reducing oxalate levels in a patient
CN116003787B (zh) 含疏水烷基链的高度支化聚(β-氨基酯)及其制备方法和mRNA递送应用
JP2012502990A5 (https=)
JP2018510863A5 (https=)
JP2009501127A5 (https=)
CN1245425A (zh) 聚(二烯丙基胺)基胆汁酸多价螯合体
RU2007127993A (ru) Сахарид-конъюгатные вакцины
JP2010512792A5 (https=)
US20130331517A1 (en) Novel Polymer Derivative Of Cytidine Metabolic Antagonist
US20130251667A1 (en) Amide dendrimer compositions
AU600460B2 (en) Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses
CN115515926A (zh) 一种聚乙二醇化脂质及其修饰的脂质体、含该脂质体的药物组合物及其制剂和应用
CN101481415A (zh) 一种新型prrs病毒受体及该受体的阻断抑制剂
CN102464801B (zh) 一种阳离子聚合物及其制备方法和用途
JP2008518953A5 (https=)
JP2020117504A5 (https=)
CN1464789B (zh) 抗流感病毒疫苗及所述病毒疫苗的制备方法
CA2602654A1 (en) Method for shielding functional sites or epitopes on proteins
CN111655758B (zh) 核酸投递用聚合物
US20100129309A1 (en) Amine polymer compositions
KR100954677B1 (ko) 증폭성 및 내부 관능성이 증진된 수지상 중합체